WMGI News and Press, Wright Medical Group N.V. From 11/27/19

NEW YORK, NY / ACCESSWIRE / November 27, 2019 / Juan Monteverde , founder and managing partner at Monteverde & Associates PC , a national securities firm headquartered at the Empire State Building in New York City, is investigating: Innophos Holdings, Inc (NASDAQ: IPHS ) ("...

NEW YORK, NY / ACCESSWIRE / November 25, 2019 / Juan Monteverde , founder and managing partner at Monteverde & Associates PC , a national securities firm headquartered at the Empire State Building in New York City, is investigating: Innophos Holdings, Inc ( IPHS ) ("Innopho...

NEW YORK, NY / ACCESSWIRE / November 23, 2019 / Juan Monteverde , founder and managing partner at Monteverde & Associates PC , a national securities firm headquartered at the Empire State Building in New York City, is investigating: Carbonite, Inc ( CARB ) related to its sa...

NEW YORK, NY / ACCESSWIRE / November 21, 2019 / Juan Monteverde , founder and managing partner at Monteverde & Associates PC , a national securities firm headquartered at the Empire State Building in New York City, is investigating: Ra Pharmaceuticals, Inc . ( NASDAQ: RARX ) re...

NEW YORK, NY / ACCESSWIRE / November 19, 2019 / Juan Monteverde , founder and managing partner at Monteverde & Associates PC , a national securities firm headquartered at the Empire State Building in New York City, is investigating: Carbonite, Inc ( CARB ) related to its ...

Acasti Pharma (NASDAQ: ACST ) resume with Buy rating and $8 (292% upside) price target at B. Riley FBR. Shares up  5%  premarket. More news on: Acasti Pharma Inc., Champions Oncology, Inc., DexCom, Inc., Healthcare stocks news, Stocks on the move, , Read more ...

Alnylam Pharmaceuticals (NASDAQ: ALNY ) initiated with Buy rating and $110 (21% upside) price target at BofA Merrill Lynch. More news on: Alnylam Pharmaceuticals, Inc., Arena Pharmaceuticals, Inc., National Vision Holdings, Inc., Healthcare stocks news, Stocks on the move, , Read more ...

AcelRx Pharmaceuticals (NASDAQ: ACRX ) downgraded to Neutral with a $2 (3% upside) price target at Credit Suisse. Shares down  3%  premarket. More news on: AcelRx Pharmaceuticals, Inc., CytomX Therapeutics, Inc., Wright Medical Group N.V., Healthcare stocks news, Stocks on the mo...

Introduction Following my review of the holdings in accounts for which I disclose and do not disclose details, I have identified the Healthcare sector as one in which I need to increase exposure; I currently have exposure to Johnson & Johnson ( JNJ ) and Becton, Dickinson and Company (...

The following slide deck was published by Wright Medical Group N.V. in conjunction with this Read more ...